MediPharm Labs (LABS) Stock Overview

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. More details

LABS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

LABS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

MediPharm Labs Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for MediPharm Labs
Historical stock prices
Current Share PriceCA$0.065
52 Week HighCA$0.12
52 Week LowCA$0.06
Beta0.29
1 Month Change-18.75%
3 Month Change-23.53%
1 Year Change-13.33%
3 Year Change0%
5 Year Change-94.40%
Change since IPO-97.05%

Recent News & Updates

Recent updates

MediPharm Labs Corp.'s (TSE:LABS) Shares Leap 54% Yet They're Still Not Telling The Full Story

Mar 26
MediPharm Labs Corp.'s (TSE:LABS) Shares Leap 54% Yet They're Still Not Telling The Full Story

MediPharm Labs Corp. (TSE:LABS) Doing What It Can To Lift Shares

Oct 11
MediPharm Labs Corp. (TSE:LABS) Doing What It Can To Lift Shares

MediPharm Labs (TSE:LABS) Is Using Debt Safely

May 29
MediPharm Labs (TSE:LABS) Is Using Debt Safely

Market Might Still Lack Some Conviction On MediPharm Labs Corp. (TSE:LABS) Even After 31% Share Price Boost

Mar 23
Market Might Still Lack Some Conviction On MediPharm Labs Corp. (TSE:LABS) Even After 31% Share Price Boost

Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?

Jan 10
Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?

MediPharm Labs (TSE:LABS) Has Debt But No Earnings; Should You Worry?

Sep 06
MediPharm Labs (TSE:LABS) Has Debt But No Earnings; Should You Worry?

MediPharm Labs Corp. (TSE:LABS) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 17
MediPharm Labs Corp. (TSE:LABS) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook

Aug 20
Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook

Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) Estimates

May 21
Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) Estimates

Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's Downgrade

Apr 06
Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's Downgrade

Is MediPharm Labs (TSE:LABS) Using Too Much Debt?

Mar 07
Is MediPharm Labs (TSE:LABS) Using Too Much Debt?

Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?

Aug 18
Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?

Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's Estimates

May 23
Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's Estimates

Shareholder Returns

LABSCA PharmaceuticalsCA Market
7D0%13.6%0.4%
1Y-13.3%-46.6%17.9%

Return vs Industry: LABS exceeded the Canadian Pharmaceuticals industry which returned -46.6% over the past year.

Return vs Market: LABS underperformed the Canadian Market which returned 17.9% over the past year.

Price Volatility

Is LABS's price volatile compared to industry and market?
LABS volatility
LABS Average Weekly Movement11.9%
Pharmaceuticals Industry Average Movement13.2%
Market Average Movement8.8%
10% most volatile stocks in CA Market18.1%
10% least volatile stocks in CA Market3.1%

Stable Share Price: LABS has not had significant price volatility in the past 3 months compared to the Canadian market.

Volatility Over Time: LABS's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2015161David Pidduckwww.medipharmlabs.com

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products.

MediPharm Labs Corp. Fundamentals Summary

How do MediPharm Labs's earnings and revenue compare to its market cap?
LABS fundamental statistics
Market capCA$26.98m
Earnings (TTM)-CA$7.47m
Revenue (TTM)CA$43.00m
0.6x
P/S Ratio
-3.6x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LABS income statement (TTM)
RevenueCA$43.00m
Cost of RevenueCA$28.20m
Gross ProfitCA$14.80m
Other ExpensesCA$22.27m
Earnings-CA$7.47m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.018
Gross Margin34.42%
Net Profit Margin-17.37%
Debt/Equity Ratio0.03%

How did LABS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/11 03:53
End of Day Share Price 2025/07/11 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MediPharm Labs Corp. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
Tamy ChenBMO Capital Markets Equity Research
Kimberly Thompson-HedlinCanaccord Genuity